Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 65.53% institutional investors, 3.35% insiders, and 31.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.80% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 65.53% | 3.35% | 31.12% |
| Sector | Healthcare Stocks | 35.34% | 11.88% | 52.77% |
| Industry | Biotech Stocks | 35.37% | 11.83% | 52.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 12.95M | 7.80% | $75.09M |
| Blackrock | 10.33M | 7.35% | $23.25M |
| Vanguard group | 11.19M | 6.30% | $87.82M |
| D. e. shaw | 7.79M | 4.69% | $45.18M |
| State street | 4.66M | 2.81% | $27.02M |
| Geode capital management | 4.29M | 2.59% | $24.89M |
| Qube research | 4.11M | 2.48% | $23.86M |
| Rosalind advisors | 3.23M | 1.95% | $18.74M |
| Nuveen | 2.92M | 1.76% | $16.92M |
| Morgan stanley | 2.57M | 1.55% | $14.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 3.23M | 7.53% | $18.74M |
| Knott david m jr | 1.06M | 3.66% | $6.15M |
| Parkman healthcare partners | 1.72M | 1.03% | $9.98M |
| Essex investment management | 747.77K | 0.69% | $4.34M |
| Voss capital | 1.39M | 0.43% | $8.04M |
| Centerbook partners lp | 1.25M | 0.39% | $7.24M |
| Redmile group | 451.10K | 0.36% | $3.67M |
| Alphacentric advisors | 45.89K | 0.27% | $266.14K |
| Granahan investment management | 921.85K | 0.26% | $5.35M |
| Armistice capital | 1.91M | 0.20% | $11.08M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 1.91M | 0.20% | 1.91M |
| Millennium management | 2.27M | 0.01% | 1.41M |
| Vanguard group | 11.19M | 0.00% | 1.36M |
| Vanguard fiduciary trust | 1.13M | 0.00% | 1.13M |
| Rosalind advisors | 3.23M | 7.53% | 1.12M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Aigh capital management | - | - | -2.57M |
| Driehaus capital management | 902.74K | 0.04% | -2.08M |
| Caxton | - | - | -2.02M |
| Acadian asset management | - | - | -971.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Armistice capital | 1.91M | 0.20% | 1.91M | $11.08M |
| Vanguard fiduciary trust | 1.13M | 0.00% | 1.13M | $6.58M |
| Norges bank | 800.70K | 0.00% | 800.70K | $6.29M |
| Divisadero street capital management, lp | 406.33K | 0.14% | 406.33K | $3.31M |
| Royce & associates lp | 256.09K | 0.01% | 256.09K | $1.49M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -2.00 |
| Nelson, van denburg & campbell wealth management group | -27.00 |
| Wealthtrak capital management | -40.00 |
| Bryn mawr trust | -40.00 |
| American capital advisory | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 241 | 3.88% | 105,125,006 | 4.27% | 65 | 2.03% | 144 | 24.14% | 55 | -26.67% |
| Dec 31, 2025 | 156 | -34.18% | 64,478,323 | -33.69% | 36 | 0.93% | 74 | -46.76% | 51 | -15.00% |
| Sep 30, 2025 | 137 | -33.50% | 56,532,097 | -37.58% | 36 | 1.07% | 80 | -25.23% | 33 | -43.10% |
| Jun 30, 2025 | 205 | - | 90,532,231 | 4.30% | 58 | 1.79% | 106 | -17.83% | 58 | 45.00% |
| Mar 31, 2025 | 204 | 24.39% | 86,739,126 | 32.43% | 56 | 2.94% | 129 | 46.59% | 39 | 14.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.95M | 2.87% | - |
| Vanguard US Total Market Shares ETF | 4.25M | 2.76% | - |
| iShares Russell 2000 ETF | 3.72M | 2.15% | 31.35K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.86M | 1.08% | 42.81K |
| CREF Stock R1 | 1.48M | 0.96% | - |
| Fidelity Small Cap Index | 1.50M | 0.87% | 17.39K |
| iShares Russell 2000 Growth ETF | 1.30M | 0.75% | 3.35K |
| Nuveen Quant Small Cap Equity R6 | 1.22M | 0.71% | - |
| State Street® SPDR® S&P® PhrmctlsETF | 1.05M | 0.61% | - |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 1.02M | 0.59% | -28.14K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 01, 2026 | Hecht Beth | See Remarks | Sell | $103.81K |
| Apr 01, 2026 | Hecht Beth | See Remarks | Sell | $99.86K |
| Mar 30, 2026 | Brady James Aloysius | - | Sell | $60.04K |
| Mar 02, 2026 | Hecht Beth | See Remarks | Sell | $706.00 |
| Mar 02, 2026 | Hecht Beth | See Remarks | Sell | $103.38K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 4 |
| 2025 Q2 | 1 | - |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools